Elizabeth Dingess-Hammond

Elizabeth Dingess-Hammond currently serves as Senior Counsel - IP at Novo Nordisk, having transitioned into this role in March 2024. Previously, Elizabeth held the position of Associate General Patent Counsel at Dana-Farber Cancer Institute from September 2022 to March 2024, where responsibilities included formulating and executing intellectual property strategies while managing a global patent portfolio. Elizabeth's expertise extends to her time at Moderna as Chief of Staff and Senior Director of Legal Operations, and at Eli Lilly and Company, where Elizabeth held multiple roles including Senior Director of the Office of Alliance Management and Assistant General Patent Counsel. Throughout these positions, Elizabeth has demonstrated significant contributions to patent strategy, legal operations, and alliance management, ensuring compliance and fostering partnerships, while providing expert legal counsel on various intellectual property matters.